IGF2BP1 and neoplasm: After further screening, we evaluated the relationship between expression of FMR1, LRPPRC, RBMX, YTHDC2, IGF2BP1 and clinical parameters, including stage, T (tumor infiltrating), N (lymphatic metastasis) and M (distant metastasis) in CRC.